ARCUS BIOSCIENCES INC shareholders Q3 2023

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

ARCUS BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
SUVRETTA CAPITAL MANAGEMENT, LLC 597,099$10,717,9270.58%
Ikarian Capital, LLC 254,876$4,575,0250.55%
Ghost Tree Capital, LLC 75,000$1,346,2500.44%
Woodline Partners LP 1,037,282$18,619,2120.22%
Alpha DNA Investment Management LLC 25,716$461,6030.19%
Mach-1 Financial Group, LLC 22,774$408,7930.17%
PLATINUM INVESTMENT MANAGEMENT LTD 204,398$3,668,9440.14%
Granahan Investment Management 195,599$3,511,0020.12%
FOX RUN MANAGEMENT, L.L.C. 19,826$355,8770.10%
Eventide Asset Management 240,000$4,308,0000.08%
External links

This page lists ARCUS BIOSCIENCES INC's shareholders in Q3 2023. To view ARCUS BIOSCIENCES INC's shareholder history, click here.